Shoulder Innovations (SI) Cash from Operations Growth (1y) (2025 - 2026)
Analysis
Shoulder Innovations (SI) Cash from Operations Growth (1y) (2025 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 185.05 Bn | 179.45 Bn | 7.27 Bn | 21.54% |
| 2 | Intuitive Surgical | 124.43 Bn | 119.22 Bn | 1.96 Bn | 48.31% |
| 3 | Medtronic | 118.52 Bn | 109.70 Bn | 6.34 Bn | 64.80% |
| 4 | Stryker | 104.55 Bn | 101.07 Bn | 4.50 Bn | 13.50% |
| 5 | Boston Scientific | 67.11 Bn | 66.57 Bn | 3.85 Bn | 14.62% |
| 6 | Edwards Lifesciences | 49.85 Bn | 45.60 Bn | 1.35 Bn | 124.64% |
| 7 | Alcon | 33.97 Bn | 32.52 Bn | 1.68 Bn | 0.99% |
| 8 | Dexcom | 32.28 Bn | 30.33 Bn | 830.00 Mn | -11.16% |
| 9 | Steris | 21.15 Bn | 20.67 Bn | 684.20 Mn | -12.60% |
| 10 | Shoulder Innovations | 413.68 Mn | 314.68 Mn | 13.44 Mn | -54.10% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -54.10% |
| Mar 31, 2026 | -90.80% |
| Dec 31, 2025 | -168.43% |
| Sep 30, 2025 | -74.95% |